Skip to main content

Evidence-Based Supplement Research

Evidence-Based Supplement Research

Lactobacillus gasseri BNR17 and Increased Beneficial Gut Microbiota

Safety in these studies

Overall tolerabilityReported
The abstract does not report any adverse events, side effects, or safety findings. It only describes efficacy outcomes such as symptom improvement, health-related quality of life, colon transit time, and fecal microbiota changes.
from: A double blind, placebo-controlled, randomized clinical trial that breast milk derived-Lac

1 of 1 paper

A double blind, placebo-controlled, randomized clinical trial that breast milk derived-Lactobacillus gasseri BNR17 mitigated diarrhea-dominant irritable bowel syndrome
- 2020-09-30
- RCT · n = 24
- Journal of Clinical Biochemistry and Nutrition 62(2)
- - S. Shin
  - Yoon Mi Choi
  - W. Kim
  - S. Hong
  - Jong‐Min Park
  - Joohee Kim
  - O. Kwon
  - E. Lee
  - K. Hahm
- PubMed: 29610559
- DOI: 10.3164/jcbn.17-73
12 Insights on
- Increased Beneficial Gut Microbiota
- High evidence
- Rigorous Journal
"BNR17 significantly increased B. fecalis, E. rectale, C. aerofaciens, F. prausnitzil and B. steroris."
Effect
Beneficial
Effect size
Small
Significant
Yes